Suppr超能文献

阿莫西林胃内漂浮型原位凝胶制剂的研制与评价

Formulation and evaluation of floating oral in situ gelling system of amoxicillin.

作者信息

Patel Dasharath M, Patel Divyesh K, Patel Chhagan N

机构信息

Department of Pharmaceutics, Shri Sarvajanik Pharmacy College, Near Arvind Baug, Mehsana, Gujarat 384 001, India.

出版信息

ISRN Pharm. 2011;2011:276250. doi: 10.5402/2011/276250. Epub 2011 Jul 28.

Abstract

Purpose. Effective Helicobacter pylori eradication requires delivery of the antibiotic locally in the stomach. High dose of amoxicillin (750 to 1000 mg) is difficult to incorporate in floating tablets but can easily be given in liquid dosage form. Keeping the above facts in mind, we made an attempt to develop a new floating in situ gelling system of amoxicillin with increased residence time using sodium alginate as gelling polymer to eradicate H. pylori. Methods. Floating in situ gelling formulations were prepared using sodium alginate, calcium chloride, sodium citrate, hydroxypropyl methyl cellulose K100, and sodium bicarbonate. The prepared formulations were evaluated for solution viscosity, floating lag time, total floating time, and in vitro drug release. The formulation was optimized using a 3(2) full factorial design. Dissolution data were fitted to various models to ascertain kinetic of drug release. Regression analysis and analysis of variance were performed for dependent variables. Results. All formulations (F(1)-F(9)) showed floating within 30 s and had total floating time of more than 24 h. All the formulations showed good pourability. It was observed that concentration of sodium alginate and HPMC K100 had significant influence on floating lag time, cumulative percentage drug release in 6 h and 10 h. The batch F(8) was considered optimum since it showed more similarity in drug release (f(2) = 74.38) to the theoretical release profile. Conclusion. Floating in situ gelling system of amoxicillin can be formulated using sodium alginate as a gelling polymer to sustain the drug release for 10 to 12 h with zero-order release kinetics.

摘要

目的。有效根除幽门螺杆菌需要在胃内局部递送抗生素。高剂量阿莫西林(750至1000毫克)难以制成胃漂浮片,但易于制成液体制剂。考虑到上述事实,我们尝试开发一种新型的阿莫西林胃内漂浮原位凝胶系统,使用海藻酸钠作为凝胶聚合物来延长其滞留时间,以根除幽门螺杆菌。方法。使用海藻酸钠、氯化钙、柠檬酸钠、羟丙基甲基纤维素K100和碳酸氢钠制备胃内漂浮原位凝胶制剂。对所制备的制剂进行溶液粘度、漂浮滞后时间、总漂浮时间和体外药物释放评价。采用3(2)全因子设计对制剂进行优化。将溶出数据拟合到各种模型以确定药物释放动力学。对因变量进行回归分析和方差分析。结果。所有制剂(F(1)-F(9))在30秒内均能漂浮,总漂浮时间超过24小时。所有制剂均具有良好的可倾倒性。观察到海藻酸钠和羟丙基甲基纤维素K100的浓度对漂浮滞后时间、6小时和10小时的累积药物释放百分比有显著影响。批次F(8)被认为是最佳的,因为它在药物释放方面(f(2)=74.38)与理论释放曲线更相似。结论。可以使用海藻酸钠作为凝胶聚合物来制备阿莫西林胃内漂浮原位凝胶系统,以零级释放动力学维持药物释放10至12小时。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验